How many insider declarations does 永安药业 have?

永安药业 has filed 1 insider declaration with AMF.

Who is the top reporting insider at 永安药业?

The top reporting insider at 永安药业 is 方锡权, based on the count of public filings.

What is the net insider buy vs sell volume on 永安药业?

Across the available history, declared buys total 0 and disposals 0.

InsidersTradesSigma

← Companies ★ Sign in to follow

永

永安药业: directors' dealings · France · AMF

SZSE:002365FR·AMFMcap 4.4Bn€

AMF ↗

Explore the full insider trade history of 永安药业, a listed issuer based in France. Shares are quoted on FR FR, under the authority of AMF. Market capitalisation: €4.4bn. The latest transaction was reported on 1 December 2025 — Sale. Among the most active insiders: 方锡权. The full history is accessible without an account.

1

Insider Decl.

0

Thresholds

·

0 ops.

Buy Volume

·

1 ops.

Sell Volume

Financial data

FY ended December 2025 · cache

12.64 €

Income statement

Revenue783.2 M€

Gross profit132.5 M€17% margin

Net income22.5 M€2.9% margin

Balance sheet & cash

Market cap4.40 Bn€

Total debt750 k€

Free Cash Flow76.8 M€

Last declaration on 1 December 2025

All Executives1 Thresholds Prospectus Other

Declarations1 total

Executives●Sale11SZSE

方

方锡权高管

50,000 shares

A股XSHE

SZSE:173000009853536740·1 Dec 2025

SZSE ↗

1 of 1 declaration